Intellia Therapeutics
NTLA
NTLA
165 hedge funds and large institutions have $1.12B invested in Intellia Therapeutics in 2020 Q3 according to their latest regulatory filings, with 26 funds opening new positions, 69 increasing their positions, 33 reducing their positions, and 25 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more ownership
Funds ownership: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
1% more funds holding
Funds holding: 164 → 165 (+1)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
1% less capital invested
Capital invested by funds: $1.13B → $1.12B (-$11.2M)
Holders
165
Holding in Top 10
2
Calls
$3.84M
Puts
$1.92M
Top Buyers
| 1 | +$14.7M | |
| 2 | +$11.8M | |
| 3 | +$8.24M | |
| 4 |
Morgan Stanley
New York
|
+$8.09M |
| 5 |
Invesco
Atlanta,
Georgia
|
+$5.35M |
Top Sellers
| 1 | -$8.79M | |
| 2 | -$4.57M | |
| 3 | -$4.33M | |
| 4 |
O
OrbiMed
New York
|
-$2.88M |
| 5 |
Sumitomo Mitsui Trust Group
Minato-Ku, Tokyo,
Japan
|
-$2.64M |